Dengue Treatment Market Research Report forecast 2017-2023
Summary - A new
market study, titled “Dengue Treatment Market: Global Market Estimation,
Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast
2017 to 2023” has been featured on Wise Guy Reports.
Market Introduction:
Dengue Treatment Market
Dengue fever is also known as break bone fever is mosquito
born and endemic disease that leads to severe flu like illness. Dengue caused
by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by
several species of mosquitos of the Aedes type, principally A. aegypti.
Symptoms of dengue include fever, headache vomiting, muscle and joint pains, and
characteristic skin rash. On infection of dengue, patient will automatically
recover within seven days. But in some cases, it may develop to life
threatening dengue hemorrhagic fever. The virus has five different types of
strains, infection with one strain usually gives lifelong immunity to that
type. Subsequent infection with a different type of dengue virus increases the
risk of severe complications.
Market Dynamics: Dengue Treatment Market
Global dengue treatment market anticipated surging its
growth owing to rise in dengue burden in tropical and sub-tropical regions,
increased government funding to fight against dengue, and unmet market needs of
managing dengue burden around the world. In addition, market players keen
interest in uplift the market by partnerships, promising dengue pipelines and
rise in medical insurance in developing countries is anticipated to drive the
market furthermore. However, lack or insufficient healthcare infrastructure in
underdeveloped and developing regions leading to serious medical conditions
going unnoticed. Furthermore, lack of awareness related to symptoms and the
high-cost of treatment are hindering the dengue-treatment market.
Market Segmentation: Dengue Treatment Market
Dengue Treatment Market has been segmented on the basis of
drug class and distribution channel
Based on drug class, dengue Treatment market is segmented
into
NSAIDS
Antibiotics
Corticosteroids
Based on distribution channel, dengue Treatment market is
segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market overview: Dengue Treatment Market
Dengue Treatment market is expected to grow at a significant
rate during forecast period. According to World Health Organization (WHO)
estimates, 50 to 100 Mn infections occur annually, including 500,000 DHF cases
and 22,000 deaths, mostly among children. Dengue treatment market is at
developing stage. Market players collaborating to other companies or research
institutions for the development of drugs for treating the dengue. For
instance, in August 2013, Johnson and Johnson Services Inc. collaborated with
biotechnology nonprofit organization The Wellcome Trust, for the development of
prevention and treatment therapies for dengue fever.
Regional Overview: Dengue Treatment Market
Geographically Dengue Treatment Market has been segmented
into following regions Viz. North America, Europe, Asia-Pacific, Latin America,
and Middle East &Africa. Latin America market expected to grow owing to
increased dengue cases. According to WHO, in 2010, 1.6 million cases of dengue
were reported in the Americas alone. In Asia-Pacific region, dengue treatment
market expected to grow at a high rate due to increase in dengue coupled with
an increase in government funding for dengue prevention and treatment. Market
players in Asia are actively participating in develepment of dengue treating
drugs to increase their market share. For instance, in May 2016, Sun Pharma
collaborated with International Centre of Genetic Engineering and Biotechnology
(ICGEB) to develep drug for treatment of dengue. South East Asia and Western
Pacific regions are more seriously affected by dengue. Hence, companies are
planning to launch their vaccines in South East Asia regions.
Market Participants: Dengue Treatment Market
Some of the market players in Dengue treatment market
include F. Hoffmann-La Roche AG (Switzerland), Sun Pharmaceutical Industries
Limited (India), Abbivax (France), Takeda Pharmaceutical Company Ltd (Japan),
Merck & Co Inc. (U.S.), and VABIOTECH (Vietnam) to name a few.
Key Market Developments: Dengue Treatment Market
In September 2017, Abbivax and Evotec AG entered into
strategic partnership to develop novel antiviral agents including dengue virus,
influenza and others.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/2868242-dengue-treatment-market-global-market-estimation-dynamics-regional-share-trends
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact
Us:
NORAH
TRENT
Ph:
+162-825-80070
(US)
Ph: +44 203
500 2763 (UK)
Comments
Post a Comment